TMP-301

Tempero Bio, Inc. · Phase 2 active Small molecule

At a glance

Generic name	TMP-301
Sponsor	Tempero Bio, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Multiple Ascending Dose Study of TMP-301 in Healthy Subjects (PHASE1)
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder (PHASE2)
A Study to Investigate the Interaction Between TMP-301 and Cocaine. (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TMP-301 CI brief — competitive landscape report
TMP-301 updates RSS · CI watch RSS
Tempero Bio, Inc. portfolio CI